(R)-NX-2127 (compound 28) is a first-in-class, orally bioavailable Brutons Tyrosine Kinase (Btk) degrader. (R)-NX-2127 mediates the degradation of transcription factors IKZF1 and IKZF3 through molecular glue interactions with the cereblon E3 ubiquitin ligase complex. NX-2127 degrades common BTK resistance mutants, including BTKC481S.
Molekulargewicht:
719.83
Reinheit:
99.76%
CAS Nummer:
[3024312-52-2]
Formel:
C39H45N9O5
Target-Kategorie:
BTK
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten